Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors.Funds will be used to further strengthen growing pipeline of first in
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Capital Increase Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Private Placement of up to EUR 30 Million (news
After years of consideration, BlackRock is dipping its toes in the crypto waters. The money manager is staring at a chilling crypto winter and possible regulations as it enters the digital-assets sector.